The results of a marketing research study are presented in this article. Аt both federal and regional levels, the pharmaceutical market for hepatoprotectors is available. Аn overall measure of the breadth, completeness and depth assortments of hepatoprotectors. Data on the number of medicines with hepatoprotective properties. The sales volume of a group of hepatoprotectors in the Russian Federation in 2020 – 2022 has been determined.
Alina V. Aydova – аssistant, department of pharmacy, no degree, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Dilyara Kh. Shakirova – professor, doctor of pharmaceutical sciences, head of the department of pharmacy, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Sayar R. Abdulhakov – аssociate рrofessor, candidate of medical sciences, head of the department of internal medicine, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
1. Titova SA, Kruglova MP. New trends in the etiology of liver diseases. European Journal of Natural History. 2023;2:42-7.
2. Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J. Hepatol. 2019;70(1):151-71. DOI: 10.1016/j.jhep.2018.09.014
3. World Health Organization. Available at: https://www.who.int/ru/. Accessed: 01 Sep 2024.
4. Okovity SV, Prikhodko VA, Bezborodkina NN, et al., editors. Hepatoprotectors: a guide for doctors. 2nd ed., revised. and additional. Moscow; 2022. DOI: 10.33029/9704-6689-6-LIV-1-240
5. Mekhtiev SN, Okovity SV, Mekhtieva OA. Principles of choosing hepatoprotectors in the practice of a therapist. Attending physician. 2016;08:44-53. ISSN 1560-5175.
6. Russian statistical yearbook. Available at: https://rosstat.gov.ru/folder/210/document/12994. Accessed: 01 Sep 2024.
7. Statistical yearbook “Republic of Tatarstan”. Available at: https://tatstat.gks.ru/publication_collection. Accessed: 01 Sep 2024.
8. Vidal. Directory of Medicines. Available at: https://www.vidal.ru/. Accessed: 01 Sep 2024.
9. State Register of Medicines. Available at: http://www.grls.rosminzdrav.ru. Accessed: 01 Sep 2024.
10. Register of Medicines of Russia. Available at: https://www.rlsnet.ru/. Accessed: 01 Sep 2024.
11. Medicines reference 003. Available at: https://003rt.ru/. Accessed: 01 Sep 2024.
12. Order of the Government of the Russian Federation of 12.10.2019 N 2406-r (as amended on 16.04.2024) “On approval of the list of vital and essential drugs, as well as lists of drugs for medical use and the minimum range of drugs required to provide medical care.” Available at: https://dgp12.mos.ru/upload/iblock/b20/w3hhnpl0ug7g6ozxj2whgprznbrimp7a.pdf. Accessed: 07 Nov 2024.
13. Aydova AV, Shakirova DKh, Mikuseva VA. Analysis of the Domestic Market of Hepatoprotectors. Sovremennaya pharmacya: vyzovy, ozhidanya, reshenya: materialy vserossiiyskoy conferencii. 23–25 March 2023; Perm. Р. 8–10. (In Russ).
14. Akhmedova GM, Khabirov FA, Shakirova DKh, Khaibullin TI. Structural analysis of the market range of medications for symptomatic multiple sclerosis treatment at the Federal and Regional levels. Vestnik sovremennoy clinicheskoy mediciny. 2018;11(issue 4):12-8. DOI: 10.20969/VSKM.2018.11(4).12-18. (In Russ).
15. Shakirova DKh, Abdulganieva DI, Ugoltsova VN. Analysis of medications for inpatient treatment of peptic ulcer disease patients. Medicinskiy vestnik Bashkortostana. 2016;11( 5(65)):53-6. (In Russ).
16. IMS retail drug audit data 2020–2022. Available at: https://dsm.ru/. Accessed: 07 Nov 2024.
The article can be purchased
electronic!
PDF format
700
DOI: 10.14489/lcmp.2024.04.pp.008-013
Article type:
Research Article
Make a request
